project id: TCGA-GBM; case submitter id: TCGA-74-6584; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20232; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1955; age at diagnosis: 20232; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 228.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.5; preservation method: Unknown; shortest dimension: 0.7; sample id: 64ebddab-6639-49c0-9ff3-956713a2c4a2; sample submitter id: TCGA-74-6584-01A; portion id: c6ae3844-4f7d-4635-acff-77ada1aa122b; portion submitter id: TCGA-74-6584-01A-11; slide id: 4652c6b6-f37a-42c5-9ffd-86031455775f; slide submitter id: TCGA-74-6584-01A-01-TS1; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;